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INTRODUCTION
Aetiology of ectopic gestation is not clearly understood. Im-
plantation of embryo, further trophoblast invasion and for-
mation of placenta are the main features of pregnancy. Pre-
vious research of abnormally implanted embryo has not
shown karyotype changes (Goddijn et al., 1996; Coste et
al., 2000). It is possible that fertilized oocyte implantation
depends on the relation between embryo and fallopian tube
cells. Probably, molecular signalling at the time of blasto-
cyst nidation is the key to explaining normal and abnormal
implantation (Attar, 2004). Inflammation may be the cause
of ectopic blastocyst implantation, or migration of concep-
tus may be impaired by hormonal or other factors.
Growth factors are important for regulation of a variety of
cellular processes and typically act as signalling molecules
between cells. The role of growth factors in aetiology of ec-
topic pregnancy has not been clearly established. The vas-
cular endothelial growth factor (VEGF) controlling angio-
genesis has been shown to participate in pathogenesis of
ectopic pregnancy (Lam et al., 2004; Daponte et al., 2005).
VEGF is elevated in maternal serum in the case of ectopic
pregnancy; however, it has shown a low predictive value for
these gestations (Daniel et al., 1999; Fasouliotis et al.,
2004). The transforming growth factor beta 1 (TGF beta 1)
superfamily is a large family of proteins that encompasses
the sub-families TGF, activins, bone morphogenetic pro-
teins (BMPs) and growth differentiation factors (GDFs).
Many cells synthesise TGF beta 1, which is a multifunc-
tional peptide that controls proliferation, differentiation and
other function of cells (Yang et al., 2003). It also partici-
pates in migration of mesenchymocytes to the site of skele-
togenesis (Atchley et al., 1991), in epithelial–mesenchymal
interaction and information of cellular condensation dictat-
ing the shape of future skeletal elements (Hall and Miyake,
2000). TGF beta 1 orchestrates complex phenomena, such
as inflammation, tissue repair, and neoplastic transforma-
tion (it controls cellular transformation from G1/G0 to S-
stage) during adult life (Roberts and Spon, 1993; Kingsley,
1994; Massaque, 1996). TGF beta 1 is known to participate
in cellular growth regulation, differentiation, apoptosis and
immunomodulation (Heldin et al., 1997).
Later, TGF beta1 becomes a promoter of tumour genesis, as
it stimulates angiogenesis, immunosupression and extracel-
lular matrix proliferation. Basic fibroblast growth factor
(bFGF), a member of the fibroblast growth factor (FGF)
family, is stored within basement membranes and binds to
the heparane sulfate chain of proteoglycane. bFGF can be
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our study was to determine the occurrence of some growth factors and their receptors in tubal
pregnancy tissues. The immunohistochemical distribution of TGF beta 1, bFGF, FGFR, NGF,
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23; P < 0.05). NGF appeared in various structures of fallopian tube and conceptus but NGFRp75
was particularly absent (U = 1; P < 0.05). IGF-1 was widely distributed in both mother and embryo
tissues, but IGF-1R only in some of the material (U = 22.5; P < 0.05). It was concluded that TGF
beta 1 is absent both in mother and conceptus tissues; fallopian tube tissues express more FGFR
than bFGF and suggest the stimulation of compensatory adaptation of the organ and the distur-
bance of angiogenesis; the presence of NGF in the fallopian tube with absence of NGFRp75 indi-
cates the failure of innervations, angiogenesis and cell interaction; the deficit of IGF-1 and the
absence of IGF-1R are suggested to be a result of gestation growth restriction and impaired inva-
sion.
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accumulated in the nucleolus, where it stimulates ribosomal
protein transcription (Bouche et al., 1987). bFGF appears in
maternal circulation during pregnancy, with peak values
late in the 2nd trimester. It is associated with a circulating
binding protein derived from the extracellular domain of the
FGFR1 receptor. The levels of bFGF in maternal serum cor-
relate positively with foetal size, both in the 2nd trimester
and at term (Hill et al., 1998). bFGF is one of the factors in-
volved in mediating the angiogenesis, proteolysis and apop-
tosis during the implantation (Zygmunt et al., 2003; Liu et
al., 2005).
Fibroblast growth factor receptor 1 (FGFR1) also is a
widely distributed membrane receptor of developing human
tissues including neurons, vascular basement membranes,
skin, and bone growth plates. It can be found in membranes
of most anchorage dependent cells also around and in their
nuclei (Hanneken, 1994; Wang, 1994).
We previously established that TGF beta1 and FGFR1 are
common growth factors in actively developing and differen-
tiating human tissue in early embryogenesis (Kukanova and
Pilmane, 2007). Nerve growth factor, a protein of the mam-
malian neurotrophin family, was originally identified as an
essential factor that promotes survival, differentiation and
myelination of neurons (Yamashita et al., 2005). Signalling
by its receptor NGFRp75 during neuronal development has
been implicated in diverse neuronal responses, including in-
creased differentiation or survival, inhibition of regenera-
tion, and initiation of apoptotic cell death (Miller and
Kaplan, 2005).
Recently it was found that NGF is not only a neurotrophin
and proinflammatory factor, but also an activator of endo-
thelial cells and can play a role in mediating angiogenesis
(Rahbek et al., 2005; Park et al., 2007). Further research
showed that NGF can be a mandatory factor for pregnancy
via inhibition of paternal MHC II molecule expression on
trophoblast cells (Tometten et al., 2005). The authors con-
cluded that NGF provides a functional link between the ner-
vous, endocrine and immune systems, translating environ-
mental or endocrine signals during pregnancy into an
immunological answer.
The biological role of NGFRp75 is to modulate tyro-
sine–protein kinase receptor activity (Mahadeo et al., 1994;
Vesa et al., 2000). However, other functions of NGFRp75
have been established: it regulates neurotrophin retrograde
transport (Curtis et al., 1995), influences Schwann cells mi-
gration (Anton et al., 1994), and activates some trans-
criptional factors (Carter et al., 1996). NGF through
NGFRp75 both activate apoptosis and prevent programmed
cell death (Casaccia et al., 1996; Frade et al., 1996;
Rabizadeh et al., 1993).
The study of embryonic nervous tissue has shown that
NGFRp75 is widespread on membranes of nerves, muscle
fibres and blood vessels, which indicates that NGFRp75 has
an important integrative role in first trimester of pregnancy
(Kukanova and Pilmane, 2006). Insulin-like growth factor 1
(IGF-1) binds to specific IGF receptors present on many
cell types in many tissues (Butler et al., 2002). IGF-1 is one
of the most potent natural activators of the cell growth and
multiplication and a potent inhibitor of programmed cell
death (Yu et al., 2008).
Almost every cell in the human body is affected by IGF-1,
especially cells in muscle, cartilage, bone, liver, kidney,
nerves, skin, and lungs. In addition to the insulin-like ef-
fects, IGF-1 can also regulate cell growth and development,
especially in nerve cells, as well as cellular DNA synthesis
(Rincon et al., 2005; Ye and D`Ercole, 2006).
Knowledge of the distribution of other growth factors in
ectopic pregnancy tissue is limited although many factors
and their receptors regulate cellular events in early embry-
onic period. Considering that growth factors orchestrate cell
growth, differentiation and proliferation during embryo-
genesis, the aim of our study was to determine the occur-
rence of some growth factors and their receptors in tissues
affected by tubal pregnancy.
MATERIALS AND METHODS
Human oviduct parts were obtained from 12 patients who
had underwent salpingoectomy for tubal pregnancy with in-
formed consent. Age, parity, contraception method, pelvic
inflammatory and sexually transmitted disease episodes,
and partner count of all the patients, were considered (Ta-
ble 1). The average patient age was 29 years (23–43).
Ectopic pregnancy was the first for three patients, second
for six, third for two and fifth for one patient. Six (50%) pa-
tients had previously documented pelvic inflammatory dis-
ease (PID) episodes, and one had undergone right-sided
salpingectomy due to previous ectopic pregnancy. Only one
of them had used an intrauterine device (IUD) for contra-
ception. The number of partners and legal abortion count
were not significantly different.
The research was conducted with the permission of Ethical
Committee of Rîga Stradiòð University (18 December
2007).
The tissue samples were fixed in 2% formaldehyde and
0.2% picric acid mixture with 0.1 M phosphate buffer (pH
7.2). Then samples were rinsed in thyroide buffer contain-
ing 10% sacharose and embedded in paraffin. The tissues
were cut into 6-ìm-thick sections and were dewaxed with
toluene and rehydrated through a graded ethanol series. The
sections were stained with haematoxylin and eosin (H&E)
using standard procedures for slide preparation.
We used the biotin–streptavidin method (Hsu et al., 1981)
for determination of transforming growth factor beta 1
(TGF beta 1 mouse monoclonal [TB21] to TGF beta 1
(ab1279), dilution 1 : 1000, Abcam UK); basic fibroblast
growth factor (FGF basic rabbit polyclonal to bFGF
(ab16828), dilution 1 : 200, Abcam, UK); fibroblast growth
factor receptor 1 (FGFR1 rabbit polyclonal to FGFR1
(ab10646), dilution 1 : 100, Abcam UK); nerve growth fac-
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tor (NGF rabbit polyclonal to NGF (ab6199), dilution 1 :
500, Abcam, UK); nerve growth factor receptor (NGFRp75
mouse polyclonal to p75 (M3507), dilution 1 : 150 DACO,
Denmark); insulin-like growth factor 1 (IGF-I goat
polyclonal to IGF-1 (MAB291), dilution 1 : 100, RnD sys-
tems, Germany); and insulin-like growth factor 1 receptor
(IGF-IR mouse monoclonal to IGF-1R (AF-305-NA), dilu-
tion 1:100, RnD Systems, Germany).
At least five microscopic fields (X200) were analysed using
a microscope (Leica DM RB, Leica Microsystems, Ger-
many).
The distribution of the factors was detected semi quantita-
tively (0/- occasional positive structures in the visual
field, + few positive structures in the visual field, ++ moder-
ate number of positive structures, and +++ numerous posi-
tive structures (Pilmane et al., 1999)). The data were ana-
lysed by nonparametric rank analysis. The Mann-Whitney
U test was used. Significance was assumed for a P value of
< 0.05.
RESULTS
Routine haematoxylin and eosin slides showed tubal
mucosal oedema and marked branching of tubal mucosal
folds. Typical features were proliferation of epitheliocytes,
infiltration of lymphocytes and leukocytes as well as capil-
lary stasis. The only embryonic structure found in the cases
of tubal pregnancy was chorionic villae binding to fallopian
tube structures and to germ membranes (yolk sac as well).
Tubal pregnancy preparations immunohisto-chemically dif-
fered in occurrence of recurred growth factors (Table 2).
Moderate cells showed FGFR and NGF immunoreactivity.
However, numerous positive reactions appeared in epithelia
of fallopian tube, nerve fibres and citolemmae of muscle
cells (Figs. 1 and 2).
IGF-1 was widely distributed in fallopian tube epithelium
(Fig. 3), while IGF-1R focally stained apical surfaces of
tubal epitheliocytes.
Cytotrophoblast and sincytiotrophoblast contained moderate
numbers of FGFR and IGF-1 positive structures. FGFR
T a b l e 1
SUMMARY OF PATIENT DATA
N Age, years Pregnancy, n Abortion, n PID, episode n Previous tube
surgery
STS Contraception Partner, n
1 23 1 0 0 0 none 5
2 24 1 0 2 0 none 1
3 24 2 1 2 0 none 3
4 25 2 1 0 0 none 4
5 25 5 3 0 0 none 1
6 26 1 0 0 0 none 3
7 27 3 2 2 0 none 3
8 30 2 1 0 0 none 1
9 31 3 2 1 0 none 1
10 35 2 1 2 0 none 5
11 38 2 1 1 Chlamidia;
micoplasmata
IUD (2 years) 1
12 43 2 0 1 Salpingectomia dx 0 none 2
PID, pelvic inflammatory disease; STS, sexually transmitted disease; IUD, intrauterine device
T a b l e 2
DISTRIBUTION OF GROWTH FACTORS IN CASES OF TUBAL PREGNANCY
Structure/ Factor FGFR bFGF NGFRp75 NGF IGF1R IGF-1 TGF beta 1
Epithelium +++ + 0/- ++ + +++ 0/-
Myocytes +++ + 0/- ++ 0/- 0/- 0/-
Endotheliocytes ++ + 0/- ++ 0/- 0/- 0/-
Nerve fibres ++ + + ++ 0/- 0/- 0/-
Mesothelium ++ + 0/- + ++ ++ 0/-
Extraembryonic mesenchyma +++ 0/1 0/- + 0/- + 0/-
Cytotrophoblast ++ 0/1 0/- 0/- 0/- ++ 0/-
Sincytiotrophoblasts ++ 0/1 0/- +++ 0/- ++ 0/-
Peripheral trophoblast + + 0/- + 0/- + 0/-
Macrophages 0/- + 0/- 0/- 0/- + 0/-
Neutrophils 0/- + 0/- 0/- 0/- + 0/-
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stained all extraembryonic mesenchymal cells, while IGF-1
stained only some of them. Extraembryonic mesenchyma
and sincytiotrophoblast showed NGF immunoreactivity
(Fig. 5).
Peripheral trophoblast focally contained FGFR, bFGF, NGF
and IGF-1 positive cells. IGF-1 and bFGF stained some
connective tissue cells, macrophages and neutrophils (Fig.
6).
A NGFRp75 focally positive reaction was observed only in
nerve fibres (Fig. 7). IGR-1R stained also mesothelium and
connective tissue cells (Fig. 8), but was absent in chorionic
structures (Fig. 9).The TGF beta 1 negative reaction was
typical for all the tissues in all cases of tubal pregnancy we
examined (Fig. 10).
The analysed tissues expressed more FGFR than bFGF (U =
23; P < 0.05). NGF appeared in various structures of the
fallopian tube and conceptus, while NGFRp75 was particu-
larly absent (U = 1; P < 0.05). IGF-1 was widely distributed
in both mother and embryo tissues, while IGF-1R stained
only some of them (U = 22.5; P < 0.05).
DISCUSSION
TGF beta 1 is essential in many reproductive processes
(Jones et al., 2006), respectively, in normal endometrial
decidualisation processes (Stoikos et al., 2008). Earlier
studies have established the role of the TGF family in
trophoblast invasion and have shown absence of TGF beta 1
in villous trophoblasts (Lyall et al., 2001; Simpson et al.,
2002). The typical negative TGF beta 1 reaction in all layers
of the fallopian tube and chorionic tissue (villous tropho-
blast as well) observed in our research is an argument for
the absence of conceptus–endometrial interaction and indi-
cates the impossibility for gestation to be continued.
The widespread distribution of FGFR1 in a multiple mature
organ system suggests an important functional role in nor-
Fig. 1. Abundant FGFR-containing structures in fallopian tube tissue. IMH
FGFR, 100×.
Fig. 2. Moderate positive response for NGF in fallopian tube epithelium.
IMH NGF, 400×.
Fig. 3. Numerous IGF-1 positive cells in fallopian tube. IMH IGF-1, 400×.
Fig. 4. Chorionic villae demonstrate moderate positive response for FGFR.
IMH FGFR, 250×.
128 Proc. Latvian Acad. Sci., Section B, Vol. 64 (2010), No. 3/4.
mal human adult tissue (Hughes, 1997). Our previous stud-
ies showed that FGFR1 participates in regulation of human
embryonic tissue formation (Kukanova and Pilmane, 2007).
We demonstrated that tubal and conceptus tissue contained
more FGFR1 than bFGF, and speculate that the excess of
receptor is due to compensatory adaptation of the organ to
pathologic process. Low occurrence of bFGF possibly indi-
cates abnormal angiogenesis and future cell growth restric-
tion.
Widely distributed NGF immunoreactivity was observed in
tubal and trophoblast tissues, with relative absence of
NGFRp75. We found NGFRp75 only in nerve fibres of the
fallopian tube. These findings suggest a break of links be-
tween endocrine, nervous and immune systems in cases of
Fig. 5. Sincytiotrophoblast shows a positive reaction for NGF. IMH NGF,
400×.
Fig. 6. Some connective tissue cells positive for bFGF. IMH bFGF, 400×.
Fig. 7. Nerve fibres stained for NGFRp75. IMH NGFRp75, 250×.
Fig. 8. IGF-1R stained only epithelium and some connective tissue cells.
IMH IGF-1R, 400×.
Fig. 9. IGF-1R negative reaction in chorionic villae. IMH IGF-1R, 250×.
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tubal implantation with failure of innervation and angio-
genesis. Thus, the important process of molecular interac-
tion between mother and conceptus tissue, essential for fur-
ther development of gestation, is absent due to lack of
NGFRp75.
IGF-1 and its receptor (IGF-1R) are essential for embryo
growth and survival. Hepatocytes and almost all human tis-
sue synthesise IGF-1 precursor, which requires further en-
zyme activation. IGF-1R also requires activation to enable
function via mature  and  chains (Khatib, 2001). IGF-1
ligand binding to its receptor IGF-1R increases proliferation
signals and cell survival. Overexpression of IGF-1R in can-
cer cells results in increased invasion and vice versa
(Zhang, 2004). In a mother, circulating levels of IGF-I are
increased during pregnancy and are correlated with foetal
birth weight. Maternal IGF-I stimulates foetal growth by ac-
tivating placental transport of nutrients to foetus (Iwashita,
1994). In cases of foetus growth retardation, a compensa-
tory increase of IGF-1 has been observed (Holmes et al.,
1999; Ozkan et al., 2008). Decidual placental cells of
pre-eclamptic women also demonstrated increased
immunoreactivity (Ozkan 2008). In fallopian tube epithe-
lium, trophoblast and connective tissue cells, we demon-
strated positive reaction for IGF-1, but all analysed tissues
were negative for IGF-1R. This finding may indicate the
possible restriction of cell growth and restriction of
trophoblast invasion in tissues affected by ectopic preg-
nancy.
Summarising our results, it is clear that formation of future
placenta and development of ectopic pregnancy are impos-
sible because of impaired molecular interaction between
mother and embryo. Therefore, important angiogenesis, in-
vasion of trophoblast and cell growth are restricted, and em-
bryo survival is doubtful. However, we cannot still be sure
if the abnormal implantation is the reason of these develop-
ment restrictions, or if developmental restrictions them-
selves represent compensatory changes in mother tissue,
which prevent this abnormal implantation. Future research
is necessary to answer these questions.
In conclusion, TGF beta 1 is absent both in mother and
conceptus tissues. Fallopian tube tissues express more
FGFR than bFGF and indicate the stimulation of compensa-
tory adaptation of the organ and disturbance of angioge-
nesis. The presence of NGF in structures of the fallopian
tube, with absence of NGFRp75, indicates the failure of
innervations, angiogenesis and cell interaction. The deficit
of IGF-1 and the absence of IGF-1R are suggested to be a
result of gestation growth restriction and impaired tropho-
blast invasion.
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AUGÐANAS FAKTORU UN TO RECEPTORU SADALÎJUMS OLVADA GRÛTNIECÎBAS AUDOS
Augðanas faktori nosaka ðûnas augðanu, diferenciâciju un proliferâciju. Mûsu pçtîjuma mçríis bija noteikt daþâdu augðanas faktoru
sadalîjumu olvada grûtniecîbas audos. TGF beta 1, bFGF, FGFR, NGF, NGFRp75, IGF-1, IGF-1R noteikðanai izmantojâm
imûnhistoíîmisko metodi. Faktoru sadalîjumu noteicâm puskvantitatîvi, datu statististiskai apstrâdei izmantojâm neparametrisko
Mann–Whitney U testu. Analizçtie audi ekspresçja FGFR vairâk nekâ bFGF (U = 23; P < 0.05). NGF novçrojams olvada un conceptus
audos, bet NGFRp75 trûkst (U = 1; P < 0.05). Gan mâtes, gan embrija audi bagâtîgi saturçja IGF-1, bet IGF-1R ir tikai daþâs struktûrâs
(U = 22.5; P < 0.05). Secinâts, ka TGF beta 1 trûkst gan mâtes, gan conceptus audos; olvadi ekspresç FGFR vairâk nekâ bFGF – tas norâda
uz orgâna kompensatoro adaptâciju un angioìençzes traucçjumiem; NGF olvadâ audos NGFRp75 trûkuma gadîjumâ raksturo inervâcijas,
angioìençzes un ðûnu mijiedarbîbas traucçjumus; IGF-1 deficîts un IGF-1R trûkums varçtu atspoguïot gestâcijas augðanas aizturi un
traucçtu trofoblasta invâziju.
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